USFDA APPLICATION NUMBER - 21183 / DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
didanosine(UNII: K3GDH6OH08) (didanosine - UNII:K3GDH6OH08) | didanosine | 400mg | 250mg | 200mg | 125mg |
Inactive Ingredients
Ingredient Name | Bristol-Myers Squibb Company |
---|---|
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311) | |
diethyl phthalate(UF064M00AF) | |
GELATIN, UNSPECIFIED(2G86QN327L) | |
methacrylic acid - methyl methacrylate copolymer (1:2)(5KY68S2577) | |
sodium hydroxide(55X04QC32I) | |
sodium starch glycolate type a potato(5856J3G2A2) | |
talc(7SEV7J4R1U) | |
titanium dioxide(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?